Peptide Drug Development

Accelerating peptide therapeutics with patients in mind.

Helping get new treatment options to patients, faster.

Experts in formulation development

Quotient Sciences' approach to formulation development is based on the physical, chemical, and biopharmaceutic properties of each peptide, and we build robust, fit-for-purpose early development programs that meet Investigational New Drug Application (IND) and other regulatory requirements.

  • Peptide characterization and preformulation
  • Biopharmaceutics profiling to guide route of delivery and formulation strategy
  • Pre-clinical and clinical formulation development and optimization
  • Phase I clinical assessment in healthy volunteers

Dosage forms for delivery routes

  • Oral, including regional delivery
  • Parenteral, including intravenous (IV), subcutaneous (SC), and intramuscular (IM)
  • Inhaled
  • Nasal
  • Topical
  • Rectal
  • Vaginal

Clinical testing capabilities

  • First-in-human (FIH) studies
  • Relative bioavailability studies to optimize drug delivery technology performance
  • Absolute bioavailability studies
  • Bioanalysis
background image - desktop
Translational Pharmaceutics, Clinical Trial Manufacturing, Peptide Drug Development

Case Study: Stealth BioTherapeutics

Read Case Study
Get in touch
Humanity can't afford to wait, so neither can we.